Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-03-01 @ 9:57 AM
Study NCT ID:
NCT02701205
Status:
UNKNOWN
Last Update Posted:
2016-03-08
First Post:
2016-02-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Sponsor:
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
QRSTPP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None